Gabelli Funds’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Gabelli Funds’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-52,657	Closed	-$2.09M	–	1187
2016 Q3	$2.09M	Buy	+52,657	New	+$588K	0.01%	775

Gabelli Funds's TBRA Position: Q4 2016 in Review

Gabelli Funds sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 52,657 shares — an estimated $2.09M sold.

Gabelli Funds first reported a position in TBRA in Q3 2016 and held it in 1 quarter. The position peaked at $2.09M in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

Gabelli Funds reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Gabelli Funds sold 52,657 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $2.09M.
Gabelli Funds first reported a position in Tobira Therapeutics, Inc. Common Stock in Q3 2016 and held it in 1 quarter.
Gabelli Funds's Tobira Therapeutics, Inc. Common Stock position peaked at $2.09M in Q3 2016.
0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on Gabelli Funds's 13F filing for Q4 2016, filed 10 Feb 2017.